Dr. David Wetter, Mayo Clinic dermatologist, discusses various features of Stevens-Johnson syndrome based on an article published in the February 2010 issue of Mayo Clinic Proceedings. http://tinyurl.com/yalgw7e
Cephalon has notified healthcare professionals about new safety information for Provigil (modafinil). Provigil is used to reduce excessive sleepiness in adult patients with narcolepsy and other sleep disorders. Provigil is not approved for any indication in children.
The revised labeling warns that Provigil can cause life-threatening skin reactions, including Stevens-Johnson Syndrome (SJS). Although benign rashes can also occur with this drug...
The Abnormal Involuntary Movement Scale (AIMSDVD.com)Training DVD is a unique resource for educators. It visually presents the AIMS exam & the entire range of "abnormal involuntary movement" associated conditions such as "tardive dystonia" using a representative range of actual patients. It scores the patients at each clips end, using the scores of a panel of medical practitioners expert in the AIMS exam. For more information go to www.AIMSDVD.co
FDA is requiring that manufacturers of metoclopramide add a boxed warning to the label about the risk of tardive dyskinesia if the drug is used for long periods of time or at high doses. Metoclopramide stimulates motility in the upper GI tract and its uses include diabetic gastroparesis and gastroesophageal reflux disease. Metoclopramide is marketed as a generic and under several trade names, including Reglan.
Tardive dyskinesia is characterized...
FDA is announcing new safety measures for oral sodium phosphate (OSP) products used for bowel cleansing before colonoscopies and other procedures. These products are associated with acute phosphate nephropathy, a rare but serious type of kidney injury. The events have been reported with the prescription products Visicol and OsmoPrep, and also over-the-counter sodium phosphate products when they are used as bowel cleansers.
FDA first warned a...